Business Standard

Kilitch Drugs (India) consolidated net profit rises 81.86% in the September 2024 quarter

Image

Sales rise 15.22% to Rs 47.47 crore

Net profit of Kilitch Drugs (India) rose 81.86% to Rs 8.62 crore in the quarter ended September 2024 as against Rs 4.74 crore during the previous quarter ended September 2023. Sales rose 15.22% to Rs 47.47 crore in the quarter ended September 2024 as against Rs 41.20 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var.Sales47.4741.20 15 OPM %12.8520.92 -PBDT10.957.60 44 PBT10.356.78 53 NP8.624.74 82

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Nov 13 2024 | 12:45 PM IST

Explore News